Brief: Antengene Says Submitted New Drug Applications For Xpovio
03/12/2020 05:05
Dec 3 (Reuters) - Antengene Corp Ltd 6996.HK :
* ANTENGENE- SUBMITTED NEW DRUG APPLICATIONS FOR XPOVIO TO
HEALTH
SCIENCES AUTHORITY OF SINGAPORE AND TO AUSTRALIAN THERAPEUTIC
GOODS ADMINISTRATION
Source text for Eikon: ID:
Further company coverage: 6996.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Antengene
See all newsBiotech firm Antengene's H1 revenue jumps on licensing deals
Brief: Antengene Corp Expects HY Profit Of RMB195 MLN-RMB238 MLN
Brief: Antengene Corp Receives Initial $60 Million Upfront Payment From UCB
Brief: Antengene Corp Intends To Repurchase Up To 67.92 Million Shares
Brief: Antengene Corp Enters Exclusive License Agreement With K2 Therapeutics For Atg-106